2005年至2014年纽约州腰椎融合术后90天再入院:一项全州队列的10年分析
该回顾性队列研究利用纽约州SPARCS数据库纳入2005至2014年86,869例腰椎融合患者,评估90天再入院率及其危险因素。总体90天再入院率为24.8%,年龄、性别、种族、保险、手术方式、手术节段数、健康服务区和合并症与再入院显著相关。
要点
- 腰椎融合术后90天再入院率为24.8%。
- 年龄≥75岁较<35岁再入院OR为1.24(95%CI 1.13-1.35)。
- 手术4至8节椎体较2至3节椎体再入院OR为2.39(95%CI 2.07-2.77)。
核心结论
- 年龄、性别、种族、保险、手术方式、手术节段数、健康服务区和合并症是90天再入院的主要危险因素。
- 本研究可在脊柱融合术前计算风险以确定高风险患者,从而预防早期再入院、改善医疗质量并减少医疗支出。
研究设计与样本
- 回顾性队列研究,利用纽约州全州规划与研究合作系统(SPARCS)纳入2005年至2014年接受腰椎融合的患者86,869例。
- 采用Cochran-Armitage检验评估90天再入院的時間趋势,采用逻辑回归分析90天再入院的预测因素。
主要发现
- 总体90天再入院率为24.8%。
- 多变量分析中,年龄≥75岁较<35岁再入院OR为1.24(95%CI 1.13-1.35)。
- 女性较男性再入院OR为1.19(95%CI 1.15-1.23);非洲裔美国人较白人OR为1.60(95%CI 1.52-1.69)。
- 医疗补助(Medicaid)较医疗保险(Medicare)再入院OR为1.42(95%CI 1.33-1.53);胸腰段融合联合手术(ICD-9 81.04)较后路腰椎椎间融合/经椎间孔腰椎融合(ICD-9 81.08)OR为2.10(95%CI 1.49-2.97)。
- 手术4至8节椎体较2至3节椎体再入院OR为2.39(95%CI 2.07-2.77);Finger Lakes健康服务区较纽约-宾夕法尼亚边界区OR为0.67(95%CI 0.61-0.73);冠状动脉疾病OR为1.26(95%CI 1.19-1.33)。
临床怎么用
- 作者认为,本研究可在脊柱融合术前进行风险计算以确定高风险患者,从而预防早期再入院、改善医疗质量并减少医疗支出。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: MINI: We assessed 90-day readmission and evaluated risk factors associated with readmission after lumbar spinal fusion surgery in New York State. The overall 90-day readmission rate was 24.8%. Age, sex, race, insurance, procedure, number of operated spinal levels, health service area, and comorbidities are major risk factors for 90-day readmission. STUDY DESIGN: Retrospective cohort study. OBJECTIVE: The aim of this study was to assess 90-day readmission and evaluate risk factors associated with readmission after lumbar fusion in New York State. SUMMARY OF BACKGROUND DATA: Readmission is becoming an important metric for quality and efficiency of health care. Readmission and its predictors following spine surgery are overall poorly understood and limited evidence is available specifically in lumbar fusion. METHODS: The New York Statewide Planning and Research Cooperative System (SPARCS) was utilized to capture patients undergoing lumbar fusion from 2005 to 2014. Temporal trend of 90-day readmission was assessed using Cochran-Armitage test. Logistic regression was used to examine predictors associated with 90-day readmission. RESULTS: There were 86,869 patients included in this cohort study. The overall 90-day readmission rate was 24.8%. On a multivariable analysis model, age (odds ratio [OR] comparing ≥75 versus <35 years: 1.24, 95% confidence interval [CI]: 1.13-1.35), sex (OR female to male: 1.19, 95% CI: 1.15-1.23), race (OR African-American to white: 1.60, 95% CI: 1.52-1.69), insurance (OR Medicaid to Medicare: 1.42, 95% CI: 1.33-1.53), procedure (OR comparing thoracolumbar fusion, combined [International Classification of Disease, Ninth Revision, ICD-9: 81.04] to posterior lumbar interbody fusion/transforaminal lumbar spinal fusion [ICD-9: 81.08]: 2.10, 95% CI: 1.49-2.97), number of operated spinal levels (OR comparing four to eight vertebrae to two to three vertebrae: 2.39, 95% CI: 2.07-2.77), health service area ([HSA]; OR comparing Finger Lakes to New York-Pennsylvania border: 0.67, 95% CI: 0.61-0.73), and comorbidity, i.e., coronary artery disease (OR: 1.26, 95% CI: 1.19-1.33) were significantly associated with 90-day readmission. Directions of the odds ratios for these factors were consistent after stratification by procedure type. CONCLUSION: Age, sex, race, insurance, procedure, number of operated spinal levels, HSA, and comorbidities are major risk factors for 90-day readmission. Our study allows risk calculation to determine high-risk patients before undergoing spinal fusion surgery to prevent early readmission, improve quality of care, and reduce health care expenditures. LEVEL OF EVIDENCE: 3.
引用
- Baaj AA, Lang G, Hsu WC, et al. 90-day Readmission After Lumbar Spinal Fusion Surgery in New York State Between 2005 and 2014: A 10-year Analysis of a Statewide Cohort. Spine (Phila Pa 1976). 2017. PMID: 28441307. doi:10.1097/BRS.0000000000002208
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。